Beta-amiloid and Phospho-tau Proteins in CSF

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Beta-amiloid and Phospho-tau Proteins in CSF trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT05915000

CSF Protein Markers as Prognostic Indicators of the Response to CSF Shunt in Normotensive Hydrocephalus

In all published series of adult chronic hydrocephalus, there is a percentage between twenty and twenty-five percent of patients who present poor results after…

Spain150 participantsStarted 2019-06-13

Treatment: Lumbar CSF protein marker determination

Beta-amiloid and Phospho-tau Proteins in CSF

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

CSF Protein Markers as Prognostic Indicators of the Response to CSF Shunt in Normotensive Hydrocephalus

All recent trials (1 shown)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

CSF Protein Markers as Prognostic Indicators of the Response to CSF Shunt in Normotensive Hydrocephalus

All recent trials (1 shown)